Does ROSUVASTATIN Cause Neoplasm malignant? 107 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 107 reports of Neoplasm malignant have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.3% of all adverse event reports for ROSUVASTATIN.
107
Reports of Neoplasm malignant with ROSUVASTATIN
0.3%
of all ROSUVASTATIN reports
4
Deaths
28
Hospitalizations
How Dangerous Is Neoplasm malignant From ROSUVASTATIN?
Of the 107 reports, 4 (3.7%) resulted in death, 28 (26.2%) required hospitalization, and 4 (3.7%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 107 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ROSUVASTATIN Alternatives Have Lower Neoplasm malignant Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN